Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1562

1.

Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.

Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):683-9. Epub 2005 May 31.

PMID:
15927412
2.

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1258-67. Erratum in: Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):921. Change, Joe T [corrected to Chang, Joe T].

PMID:
15001271
3.

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1268-79.

PMID:
15001272
4.

Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.

Schwarz M, Alber M, Lebesque JV, Mijnheer BJ, Damen EM.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):561-70.

PMID:
15890601
5.
7.
8.

Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.

Longobardi B, De Martin E, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, Calandrino R.

Radiother Oncol. 2005 Nov;77(2):148-56. Epub 2005 Nov 2.

PMID:
16260056
9.

Dose escalation of chart in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?

McGibney C, Holmberg O, McClean B, Williams C, McCrea P, Sutton P, Armstrong J.

Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):339-50.

PMID:
10487554
10.

Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland.

Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C, Dearnaley DP, Webb S.

Radiother Oncol. 2001 Aug;60(2):173-80.

PMID:
11439212
11.

[Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].

Huang XB, Jiang GL, Chen JY, Chen LF, Hu WG.

Ai Zheng. 2006 Jul;25(7):855-60. Chinese.

PMID:
16831277
12.

Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.

Knab B, Rash C, Farrey K, Jani AB.

Med Dosim. 2006 Winter;31(4):292-7.

PMID:
17134669
13.
14.

Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy.

Kron T, Grigorov G, Yu E, Yartsev S, Chen JZ, Wong E, Rodrigues G, Trenka K, Coad T, Bauman G, Van Dyk J.

Phys Med Biol. 2004 Aug 21;49(16):3675-90.

PMID:
15446797
15.

Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.

Mavroidis P, Ferreira BC, Shi C, Lind BK, Papanikolaou N.

Phys Med Biol. 2007 Jul 7;52(13):3817-36. Epub 2007 May 31.

PMID:
17664579
16.

Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.

Verbakel WF, van Reij E, Ladenius-Lischer I, Cuijpers JP, Slotman BJ, Senan S.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e297-303. doi: 10.1016/j.ijrobp.2011.12.059.

PMID:
22579380
17.

Automated selection of beam orientations and segmented intensity-modulated radiotherapy (IMRT) for treatment of oesophagus tumors.

Woudstra E, Heijmen BJ, Storchi PR.

Radiother Oncol. 2005 Dec;77(3):254-61. Epub 2005 Jul 18.

PMID:
16026873
18.

Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques.

Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, Conway J, Webb S.

Radiother Oncol. 2001 Aug;60(2):163-72.

PMID:
11439211
19.

Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.

Li XA, Wang JZ, Jursinic PA, Lawton CA, Wang D.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1251-7.

PMID:
15752907
20.

Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.

Dvorak P, Georg D, Bogner J, Kroupa B, Dieckmann K, Pötter R.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1572-81.

PMID:
15817364

Supplemental Content

Support Center